Ann: Phase 1 trial commences Q1, 2022 for Emyrias ultra-pure CBD, page-5

Excellent news, can’t wait for this trial to progress. We know it’ll be safe as CBD has a near flawless safety profile and hopefully will have superior pharmacokinetics to Epidiolex as a kicker.

then onto phase 3 and show this stuff works! Follow on with TGA approval and EMD-RX5 will be the first over the counter Aussie developed CBD/medical cannabis product for “generalised psychological distress” (read: everyone post pandemic) = colossal market !!

if they pull it off I’ll really set these guys up as local market leaders…